Univest
Univest
  • Markets
  • Kwality Pharma vs SMS Pharma vs Panacea Biotec: Which Stock Should You Track

    • October 14, 2026
    • Posted by: Harsh Piplani
    • Category: Market
    No Comments
    Kwality Pharma vs SMS Pharma vs Panacea Biotec: Which Stock Should You Track

    Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec compared on market cap, PE, PB, ROE, dividend yield and debt to equity, as of October 2026.

    read more
  • Eris vs Emcure vs Lupin: Which Stock Should You Track

    • October 7, 2026
    • Posted by: Chaitanya Auti
    • Category: Market
    No Comments
    Eris vs Emcure vs Lupin: Which Stock Should You Track

    Eris Lifesciences vs Emcure Pharmaceuticals vs Lupin compared on market cap, PE, PB, ROE, dividend yield and debt to equity, as of October 2026.

    read more
  • FDC vs IOL Chemicals vs Innova Captab: Which Stock Should You Track

    • October 7, 2026
    • Posted by: Harsh Piplani
    • Category: Market
    No Comments
    FDC vs IOL Chemicals vs Innova Captab: Which Stock Should You Track

    FDC Limited vs IOL Chemicals and Pharmaceuticals vs Innova Captab compared on market cap, PE, PB, ROE, dividend yield and debt to equity, as of October 2026.

    read more
  • Eris Lifesciences vs Akums Drugs vs Innova Captab: Which Stock Should You Track

    • September 28, 2026
    • Posted by: Harsh Piplani
    • Category: Market
    No Comments
    Eris Lifesciences vs Akums Drugs vs Innova Captab: Which Stock Should You Track

    Eris Lifesciences vs Akums Drugs vs Innova Captab compared on market cap, PE, ROE and dividend yield, as of September 2026.

    read more
  • Glenmark Pharma vs Gland Pharma vs Emcure Pharma: Which Stock Should You Track

    • September 28, 2026
    • Posted by: Chaitanya Auti
    • Category: Market
    No Comments
    Glenmark Pharma vs Gland Pharma vs Emcure Pharma: Which Stock Should You Track

    Glenmark Pharmaceuticals vs Gland Pharma vs Emcure Pharmaceuticals compared on market cap, PE, PB, ROE, dividend yield and debt to equity, as of September 2026.

    read more